Latest filing published 01 Oct 2026 for CERENOME, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -53.4%Entry US$36.50 · Close at T+365 US$17.00
- -86.9%Entry US$55.25 · Close at T+365 US$7.25
- -52.1%Entry US$210.00 · Close at T+365 US$100.50
- -71.0%Entry US$375.00 · Close at T+365 US$108.75
- -73.3%Entry US$562.50 · Close at T+365 US$150.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew John Hugh MacIntyre Sims: trading record in brief
Andrew John Hugh MacIntyre Sims (finance chief) discloses dealings in Cerenome, Inc. to SEC (Form 4). We count 16 filings; the first trade dates from 27 July 2021 and the latest from 1 October 2026.
Every open-market trade on record is a purchase: 9 purchases worth €38k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 7 option exercises.
In size, the median ticket on the buying side is €3,444. Clusters matter here: 5 out of 9 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 7 purchases show a median change of -30.7%, with the price up in 14% of them. This is a record of the past, not a forecast.
The newest entry dates from 1 October 2026: an option exercise, in Cerenome, Inc. The most recent open-market purchase was published on 5 November 2025, 368 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew John Hugh MacIntyre Sims
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,533 shares0Common StockSEC:0001193125-26-409857:0
- 1,165 shares0Common StockSEC:0001193125-26-409857:1
- 287 shares0Common StockSEC:0001193125-26-409857:2
- 38,323 shares0Common StockSEC:0001193125-26-135711:0
- 29,129 shares0Common StockSEC:0001193125-26-135711:1
- 38,323 shares0Common StockSEC:0001193125-26-000966:0
- 20,000 shares@ US$0.5125.5% of flowCommon StockSEC:0001193125-25-265866:0Canonical exit: 2 Feb 2026 (T+90)
- 38,323 shares0Common StockSEC:0001193125-25-230291:0
- 4,098 shares@ US$1.2713.6% of flowCommon StockSEC:0000950170-24-105330:0Canonical exit: 9 Dec 2024 (T+90)
- 4,902 shares@ US$2.0426.8% of flowCommon StockSEC:0000950170-24-057456:0Canonical exit: 6 Aug 2024 (T+90)
- 3,000 shares@ US$0.6725.5% of flowCommon StockSEC:0001209191-22-025719:0Canonical exit: 25 Jul 2022 (T+90)
- 2,000 shares@ US$1.09995.7% of flowCommon StockSEC:0001209191-22-015201:0Canonical exit: 30 May 2022 (T+90)
- 1,000 shares@ US$1.86434.6% of flowCommon StockSEC:0001209191-21-062868:0Canonical exit: 31 Jan 2022 (T+90)
- 2,000 shares@ US$1.66948.3% of flowCommon StockSEC:0001209191-21-061723:0Canonical exit: 24 Jan 2022 (T+90)
- 1,986 shares@ US$2.059.9% of flowCommon StockSEC:0001209191-21-048660:0Canonical exit: 25 Oct 2021 (T+90)
15 of 15 declarations
